Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationHematopoietic Stem CellsTransplantation ConditioningTransplantation, HomologousMelphalanAntigens, CD34Granulocyte Colony-Stimulating FactorHematologic NeoplasmsLeukapheresisCombined Modality TherapyStem Cell TransplantationBlood Component RemovalCyclophosphamideMultiple MyelomaGraft vs Host DiseaseStem CellsAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsBusulfanTreatment OutcomeBone Marrow TransplantationGraft SurvivalLymphoma, Non-HodgkinEtoposideThiotepaAntineoplastic Agents, AlkylatingHematopoiesisRemission InductionRecurrenceCytophagocytosisCarmustineIfosfamideSalvage TherapyCord Blood Stem Cell TransplantationVincristineAmyloidosisTransplantation ChimeraCytarabineDisease-Free SurvivalHodgkin DiseaseTissue DonorsRetrospective StudiesWhole-Body IrradiationNeoplasmsSurvival RateTime FactorsSurvival AnalysisHistocompatibilityInfectionLymphoma, T-CellHistocompatibility TestingDoxorubicinPlatelet CountImmunosuppressive AgentsPOEMS SyndromeLeukemia, Myeloid, AcuteLeukemiaTransplantation, IsogeneicPrednisoneBlood Cell CountCarboplatinVidarabineFollow-Up StudiesRecombinant ProteinsDexamethasoneBlood CellsGraft vs Leukemia EffectAntineoplastic AgentsCytomegalovirus InfectionsProspective StudiesBone Marrow PurgingEmbryonic Stem CellsBone MarrowLymphomaCell DifferentiationFatal OutcomeAdult Stem CellsBone Marrow CellsMyelodysplastic SyndromesFeasibility StudiesFlow CytometryImmunophenotypingCell SeparationMesenchymal Stem Cell TransplantationAnemia, AplasticLeukemia, Myelogenous, Chronic, BCR-ABL PositiveStem Cell NicheHematologic DiseasesColony-Forming Units AssayCells, CulturedT-LymphocytesCell LineageLymphocyte DepletionBlood Transfusion, AutologousLiver TransplantationHLA AntigensOpportunistic Infections